procurement of medical stores out of dglp fund fy 2022-23 , human insulin analogue glargine inj, 100 iu / ml ( recombinant dna origin ) 300 iu disposable pen with 5 needles per pen , inj human insulin analogue aspart premix 25%, 75 % insulin protamine aspart suspension, 100 iu / ml ( monocomponent insulin recombinant dna origine ) 3 ml pfs / pfp , cell culture rabies vaccine vial of 1 ml , isapgol / ispaghula husk 3.5 gm , cream luliconazole, tube of 15 gm , amoxycillin 875 mg + clavulanic acid 125 mg tab , anti phlebitis cream tube of 15 g / 20 g , insulin lispro pen needle